#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Anaemia Myotonia Glomerulonephritis rapidly progressive Metabolic disorder Depression Immunoglobulin G4 related disease Pemphigus Thermal burn Cluster headache Rosai-Dorfman syndrome Germ cell cancer Primary adrenal insufficiency Thrombocytopenia Liver abscess Retinopathy proliferative More trials…

    Learn about Rare Diseases

    Arterial tortuosity syndrome – Life with Disease Cystic fibrosis lung Optic glioma – Treatment Aicardi-Goutieres syndrome – Life with Disease Systemic mastocytosis – Life with Disease Atypical teratoid/rhabdoid tumour of CNS Cholangitis sclerosing – Treatment Bronchiolitis obliterans syndrome – Trials in Disease Ewing’s sarcoma recurrent – Treatment Haemophilia – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Azenosertib Oms906 Tipapkinogene Sovacivec Timolol ALLERGEN EXTRACTS Gsk3858279 Entinostat Deferoxamine Ergocalciferol RIKKUNSHITO Iron Sucrose Sertindole Tarlatamab Simoctocog Alfa Cefalexin GRISNILIMAB SETARITOX Desonide Pimavanserin Tartrate 20-HYDROXYECDYSONE Ecoo16 More therapies…

    Learn about Your Condition

    Alopecia areata Urticaria Malignant mast cell neoplasm Eclampsia C3 glomerulopathy Cytomegalovirus infection Skin bacterial infection Spinal cord injury cervical Aortic valve stenosis Hepatic fibrosis Familial mediterranean fever Mantle cell lymphoma Loeys-Dietz syndrome Adenovirus infection Left ventricular failure More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Haga Hospital

Haga Hospital

Els Borst-Eilersplein 275, Hague, 2545 AA, Netherlands

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Nipocalimab for Adults with Warm Autoimmune Hemolytic Anemia

    Not recruiting

    4 1 1
    Investigated Drugs:
    • Nipocalimab
    • Sodium Chloride
    Czechia France Germany Greece Hungary Italy +3

  • Study Comparing Talquetamab, Pomalidomide, and Teclistamab for Patients with Relapsed or Refractory Myeloma After 1 to 4 Prior Treatments

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Talquetamab
    • Teclistamab
    • Bortezomib
    Austria Belgium Czechia Denmark France Germany +7

  • Study of Rilzabrutinib for Adults with Relapsed Immune Thrombocytopenia

    Not recruiting

    1 1 1
    Investigated Drugs:
    • Rilzabrutinib
    Bulgaria Czechia The Netherlands

  • Study of Daratumumab with Drug Combination for Patients with Newly Diagnosed Multiple Myeloma Eligible for High-Dose Therapy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Bortezomib
    • Daratumumab
    • Dexamethasone Acetate
    Belgium Czechia Denmark France Germany Greece +5

  • Study Comparing Sonrotoclax and Zanubrutinib with Venetoclax and Obinutuzumab for Patients with Untreated Chronic Lymphocytic Leukemia

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Zanubrutinib
    • N-[4-({[(1R,4R)-4-Hydroxy-4-Methylcyclohexyl]Methyl}Amino)-3- Nitrobenzene-1-Sulfonyl]-4-(2-{(2S)-2-[2-(Propan-2-Yl)Phenyl]Pyrrolidin1-Yl}-7-Azaspiro[3.5]Nonan-7-Yl)-2-[(1H-Pyrrolo[2,3-B]Pyridin-5- Yl)Oxy]Benzamide
    • Obinutuzumab
    Austria Czechia France Germany Italy The Netherlands +3

  • Study Comparing Loncastuximab Tesirine and Rituximab with Standard Treatment for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma
    Investigated Drugs:
    • Loncastuximab Tesirine
    • Dexamethasone
    • Gemcitabine
    Belgium Czechia France Hungary Italy The Netherlands +2

  • Study of Belzutifan with Lenvatinib versus Cabozantinib in Adults with Advanced Renal Cell Carcinoma Who Have Previously Received Anti-PD-1/L1 Treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal cell carcinoma
    Investigated Drugs:
    • Belzutifan
    • Cabozantinib
    • Lenvatinib
    Austria Belgium Czechia Finland France Germany +7

  • Study on Crizanlizumab for Adolescents and Adults with Sickle Cell Disease Experiencing Vaso-Occlusive Crises

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Sickle cell anaemia
    • Sickle cell disease
    Investigated Drugs:
    • Crizanlizumab
    Belgium Finland France The Netherlands Spain

  • Study Comparing Elranatamab and Lenalidomide for Patients with Newly Diagnosed Multiple Myeloma After Stem-Cell Transplantation

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Elranatamab
    • Human Normal Immunoglobulin
    • Lenalidomide
    Austria Belgium Czechia Finland France Germany +8

  • Study on Epcoritamab, Rituximab, and Lenalidomide for Adults with Untreated Follicular Lymphoma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • B-cell lymphoma
    • Follicular lymphoma
    Investigated Drugs:
    • Epcoritamab
    • Bendamustine Hydrochloride
    • Cyclophosphamide
    Belgium Bulgaria Croatia Czechia Denmark France +11
Previous Page
1 … 8 9 10 11 12 … 14
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!